M. Logue

440 total citations
9 papers, 356 citations indexed

About

M. Logue is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. Logue has authored 9 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. Logue's work include Alzheimer's disease research and treatments (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). M. Logue is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). M. Logue collaborates with scholars based in United States. M. Logue's co-authors include Richard J. Wurtman, John H. Growdon, Steven H. Zeisel, Sheila G. Magil, J. K. Blusztajn, Eldad Melamed, Franz Hefti, Ignacio López G.‐Coviella, Candace J. Gibson and Richard M. Niles and has published in prestigious journals such as Neurology, Brain Research and Life Sciences.

In The Last Decade

M. Logue

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Logue United States	7	126	120	95	51	45	9	356
Václav Lisý Czechia	11	140 1.1×	145 1.2×	80 0.8×	53 1.0×	67 1.5×	18	406
Jyrki Rintala Finland	10	173 1.4×	188 1.6×	63 0.7×	68 1.3×	31 0.7×	12	568
Amiram I. Barkai United States	12	141 1.1×	166 1.4×	68 0.7×	35 0.7×	13 0.3×	34	447
Toshikiyo Shohmori Japan	16	261 2.1×	136 1.1×	81 0.9×	32 0.6×	34 0.8×	41	578
J. Jean Mitchell United States	8	84 0.7×	126 1.1×	60 0.6×	13 0.3×	12 0.3×	10	416
Gian Luigi Piccinin Italy	9	88 0.7×	96 0.8×	95 1.0×	149 2.9×	43 1.0×	24	394
F. de Balbian Verster United States	12	147 1.2×	257 2.1×	122 1.3×	15 0.3×	24 0.5×	19	476
Annalisa LoGerfo Italy	11	216 1.7×	69 0.6×	144 1.5×	40 0.8×	55 1.2×	17	462
A. Tallón-Barranco Spain	14	156 1.2×	106 0.9×	191 2.0×	56 1.1×	11 0.2×	18	541
Sally Abdelmoaty Sweden	7	70 0.6×	48 0.4×	117 1.2×	85 1.7×	56 1.2×	8	447

Countries citing papers authored by M. Logue

Since Specialization

Citations

This map shows the geographic impact of M. Logue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Logue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Logue more than expected).

Fields of papers citing papers by M. Logue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Logue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Logue. The network helps show where M. Logue may publish in the future.

Co-authorship network of co-authors of M. Logue

This figure shows the co-authorship network connecting the top 25 collaborators of M. Logue. A scholar is included among the top collaborators of M. Logue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Logue. M. Logue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Blusztajn, J. K., et al.. (1990). Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Research. 536(1-2). 240–244. 79 indexed citations

Conlay, Lydia A., R. J. Wurtman, J. K. Blusztajn, et al.. (1989). Effects of running the Boston marathon on plasma concentrations of large neutral amino acids. Journal of Neural Transmission. 76(1). 65–71. 12 indexed citations

Wurtman, R J, İsmail H. Ulus, J. K. Blusztajn, et al.. (1989). Choline levels, the regulation of acetylcholine and phosphatidylcholine synthesis, and Alzheimer's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 1(1-2). 15–15. 1 indexed citations

Logue, M., John H. Growdon, Ignacio López G.‐Coviella, & Richard J. Wurtman. (1985). Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sciences. 37(5). 403–409. 49 indexed citations

Gibson, Candace J., M. Logue, & John H. Growdon. (1985). CSF Monoamine Metabolite Levels in Alzheimer's and Parkinson's Disease. Archives of Neurology. 42(5). 489–492. 25 indexed citations

Growdon, John H., Eldad Melamed, M. Logue, Franz Hefti, & Richard J. Wurtman. (1982). Effects of oral L-tyrosine administration of CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sciences. 30(10). 827–832. 78 indexed citations

Zeisel, Steven H., John H. Growdon, Richard J. Wurtman, Sheila G. Magil, & M. Logue. (1980). Normal plasma choline responses to ingested lecithin. Neurology. 30(11). 1226–1226. 100 indexed citations

Niles, R M & M. Logue. (1979). Retinoid acid increases cyclic amp-dependent protein kinase activity in b16-f1 mouse melanoma cells. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 166. 2 indexed citations

Niles, Richard M. & M. Logue. (1979). Isolation and characterization of a variant of B16‐mouse melanoma resistant to MSH growth inhibition. Journal of Supramolecular Structure. 11(2). 251–258. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact